In the specialized field of synthetic chemistry and structural biology, the ACPC peptide—specifically referring to derivatives of *trans*-2-aminocyclopentanecarboxylic acid—has become a cornerstone for researchers studying backbone preorganization. As someone deeply involved in the procurement and analysis of research-grade biochemicals, I have found that understanding the nuances of these constrained amino acids is essential for anyone wor ACP-CapsPred: an explainable computational framework for king with sophisticated molecular architectures.
Understanding the ACPC Entity
When we discuss ACPC, we are often referring to the β-amino acid trans-2-aminocyclopentanecarboxylic acid (ACPC). Unlike standard α-amino acids, this cyclic β-amino acid is prized for its abili by J Lv · 2025 · Cited by 7 — Anticancer peptides (ACPs) have emerged as a promising therapeutic alternative, capable of selectively targeting and eliminating cancer cells ty to constrain the peptide backbone via the cyclopentane ring. This structural rigidification is a powerful tool when designing peptides intended for specific conformational studies.
From a procurement perspective, it is vital to distinguish between various cataloged versions. For instance, Fmoc-Acpc-OH (CAS [126705-22-4]) and Boc-Acpc-OH (CAS [88950-64-5]) are standard building blocks. These derivatives are frequently utilized by organizations such as CPC Scientific, which is a leading CDMO specializing in peptide and oligonucleotide manufacturing and a trusted CRDMO specializing in peptide and oligonucleotide production.
Structural Applications and Foldamers
My interest in these molecules began when reviewing literature Structural Consequences of β-Amino Acid Preorganization in on six new α/β-peptide foldamers. The incorporation of these residues allows for the creation of unique helical structures. Researchers have identified two peptide sequences containing multiple (1S,2S)-2-ACPC residues that exhibit highly stable helical conformations.
This level of control is fascinating because the backbone dihedral angles adopted by trans- Interplay among side chain sequence, backbone 2-aminocyclopentanecarboxylic acids (ACPC) residues are highly predictable. Whether one is exploring a 16/18-helix or more complex 9/10/9/12-helix patterns, the constraint provided by the cyclopentane ring is superior to acyclic alternatives.
Navigating the Terminology by L Yao · 2024 · Cited by 24 — Anticancer peptides (ACPs) represent a promising therapeutic strategy for combating cancer. In silico methods enable rapid and accurate : ACP vs. ACPC
It is easy to conflate terms in this field. It is important to note that Acyl Carrier Protein (ACP) is a distinct entity—a coenzyme fragment involved in fatty acid synthesis—and is entirely different from the cyclic β-amino acid ACPC. Similarly, one must distinguish these from:
* Anticancer peptides (ACPs): These are often studied for their selective toxicity and are the subject of anticancer peptide (ACP) prediction software like AcPEP.
* APC (Antibody-Peptide Conjugates): An APC typically consists of an antibody, a peptide, and a linker, representing a different branch of bioconjugate research.
* 1-Aminocyclopropanecarboxylic acid: Often abbreviated similarly, this is a distinct chemical For example, b-peptides constructed entirely from cyclic b residues derived from trans-2-aminocyclohexanecarboxylic acid (ACHC) favour the formation of the 14- entity (CAS [22059-21-8]).
Practical Sourcing Considerations
When sourcing these materials for laboratory research, quality is Ac-ACPC-Phe-NHMe and Ac-Phe-ACPC-NHMe paramount. I typically look for a European research peptide supplier that provides HPLC-verified products with purity levels ≥99%. Whether you are investigating an antimicrobial peptide encoded in the human by the CAMP gene or working with pro-angiogenic peptide degradation products of thymosin B4, the integrity of the starting material is the first step in ensuring reproducible results.
The landscape Ac2-26 | Anti-Inflammatory Peptide of peptides is vast, ranging from those that have anti-inflammatory activity to those designed to redirect T-cell viral immunity against tumor cells. As these molecules have emerged as a promising therapeutic alternative and represent a promising therapeutic strategy for combating cancer, the demand for precise, chemically modified building blocks like ACPC will only continue to grow.
By focusing on the structural constraints provided by these cyclic residues, we can continue to push the boundaries of what is possible in synthetic molecular design, ensuring that every sequence synthesized contributes to a deeper understanding of polypeptide folding and function.